Gyala, Therapeutics

Gyala Therapeutics inicia un ensayo clínico de fase I/ IIa de una terapia con células CAR-T

Veröffentlicht: 20.03.2026 um 08:35 Uhr, prnewswire.co.uk

Gyala Therapeutics Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

en | boerse | 68929686 |